WebbThe use of standardized criteria to define tumor shrinkage, stable disease, and progressive disease (PD) are of major importance when designing clinical trials and defining … http://www.jcog.jp/doctor/tool/14_20_RECIST.pdf

实体肿瘤疗效评价标准：RECIST 1.1 - 知乎

WebbiRECIST vs RECIST 1.1: Unchanged RECIST 1.1 iRECIST Definitions of measurable, non-measurable disease √ Definitions of target (T) and non target (NT) lesions √ Measurement and management of nodal disease √ Calculation of the sum of measurement (SOM) √ Definitions of CR, PR, SD and their duration √ Confirmation of CR and PR √ Webbdzi w nowotworach litych (RECIST — Response Evaluation Criteria In Solid Tumours) w wersji 1.0. [2]. Po kilku latach praktycznego stosowania kryteriów RECIST w 2009 roku Eisenhauer i wsp. [3] opublikowali uaktualnioną i obecnie zalecaną wersję 1.1 kryteriów RE-CIST. Kryteria RECIST 1.1. są standardem oceny odpowiedzi w badaniach ... hardwired under cabinet lights

―日本語訳 JCOG

WebbIn RECIST 1.1 we have five response categories: Complete Response (CR), Partial Response (PR), Stable Disease (SD), Progressive Disease (PD), and Not Evaluable (NE). iRECIST requires additional follow-up imaging (4-8 weeks) for the confirmation of an assessment of progressive disease and have WebbThe guidelines. The revised RECIST guidelines (version 1.1) are available here for free with permission from the European Journal of Cancer (EJC). The guidelines and accompanying articles were published in a special issue of EJC in January 2009. guidelines. Webbrecist疗效评价标准 非目标病灶的评价： 完全缓解（CR）：所有非目标病灶消失和肿 如果胸腔积液（或心包积液）的多次细胞学 检查未能找到癌细胞，胸腔积液（或心包积 液）又是非血性或非渗出性的，临床判断该 胸腔积液（或心包积液）与肿瘤无关，这种 类型的胸腔积液（或心包积液）不影响 ... hardwired under cabinet kitchen led lighting